MockQuestions

GlaxoSmithKline Mock Interview

Question 29 of 35 for our GlaxoSmithKline Mock Interview

GlaxoSmithKline was updated by on May 24th, 2022. Learn more here.

Question 29 of 35

In your opinion, what is the biggest development in Biotechnology in the past three years?

"There have been so many developments in biotechnology in the past three years, but I feel that the biggest was the development in gene editing. It's an incredibly controversial and intriguing practice."

Next Question

How to Answer: In your opinion, what is the biggest development in Biotechnology in the past three years?

Advice and answer examples written specifically for a GlaxoSmithKline job interview.

  • 29. In your opinion, what is the biggest development in Biotechnology in the past three years?

      How to Answer

      The term 'biotechnology' refers to the use of cells and molecules to create a product within medicine, genetic testing, or even agriculture. Tell the interviewer what you see as the most significant development in the past few years.

      Written by Krista Wenz on May 24th, 2022

      1st Answer Example

      "There have been so many developments in biotechnology in the past three years, but I feel that the biggest was the development in gene editing. It's an incredibly controversial and intriguing practice."

      Written by Krista Wenz on May 24th, 2022

      2nd Answer Example

      "There is a multitude of biotech developments from which to choose! I recently read about new methods of manipulating human cells to beat a range of diseases. According to Fortune Magazine, Chinese scientists have launched the first CRISPR gene-editing trial for the treatment of cancer. It's all pretty incredible, isn't it?"

      Written by Krista Wenz on May 24th, 2022

      Anonymous Interview Answers with Professional Feedback

      Anonymous Answer

      "There have been multiple advances in IT, but the biggest is AI, automation and machine learning."

      Rachelle's Feedback

      There have been many developments, indeed! Your reply is a good start, and I encourage you to include more detail regarding the advancements you have seen (as they relate to GSK) in the areas of AI, ML, and Automation.